CTLT | Catalent
106.68 -3.16 (-2.88%)
CTLT Price Profile
Open
$107.73
CLOSE
$106.68
DAY RANGE
106.01 - 108.74
52 WEEK RANGE
86.34 - 142.64
MARKET CAP
17.31B
Trading volume
321.6K
Prev. Close
109.84
50 Day MA
121.66
Shares Outstanding
171.19M
Public Float
170.44M
Average Volume
1.11M
Beta
1.32
PEG Ratio
1.68
Shares Shorted
1.41M
% OF SHARES SHORTED
1.06%
Short Ratio
1.33
1 Year Performance
-8.40%
Diluted EPS (TTM)
3.18
Q Revenue Growth
0.21
Ebitda
1.02B
Gross Profit (TTM)
1.35B
Total Cash (MRQ)
2.02B
Total Debt (MRQ)
4.32B
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
Catalent (CTLT) company profile
Catalent Inc. (NYSE: CTLT) is a medical company that provides delivery technologies and development and manufacturing solutions for drugs, protein, cell, gene therapy biologics and consumer health products. It operates through the segments of Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. Catalent also provides packaging services, labelling, storage, distribution, and inventory management for clinical drug trials.
